STIM Neuronetics Inc
Company Analysis
Latest News
🔴 Neuronetics is trading 7.7% down in pre-market with no clear company-specific catalyst identified
Neuronetics is trading at $1.80, down 7.7%, with no clear company-specific announcement identified to explain its October 16 pre-market decline. - Shares...
🟢 Neuronetics is trading 5% up today as healthcare sector gains
Neuronetics is trading 5.04% higher at $1.98 alongside a healthcare sector rally; no company-specific catalyst was identified. - The healthcare sector is up...
🔴 Neuronetics is trading 5% down on October 14, 2026, as inflation stokes rate concerns
Neuronetics is trading 5.03% down at $1.89 as hotter-than-expected September inflation heightened rate-hike concerns and weighed on U.S. stocks. - Reuters...
🔴 Neuronetics is trading 5% down today; no fresh company catalyst identified
Neuronetics is trading at $2.02 (-5.16%), with no specific fresh company catalyst identified. - No specific Neuronetics announcement explaining the October 13...
🟢 Neuronetics is trading 5% up
Neuronetics is trading 5.32% higher at $2.27 on October 5, but no specific catalyst has been identified. - Shares are up from the October 2 close of $2.16. -...
🟢 Neuronetics is trading 5% up in pre-market — no fresh company-specific catalyst identified
Neuronetics is trading at $2.27, up 5.09% before the October 5, 2026 open; no fresh company-specific catalyst was identified to explain the move. - The price...
🔴 Neuronetics is trading 5.8% down without a fresh company catalyst
Neuronetics is trading at $2.21, down -5.77%, with no fresh company-specific announcement identified to explain the October 1 decline. - Neuronetics’...
🔴 Neuronetics is trading 5% down today amid a 1.33% healthcare-sector decline
Neuronetics is trading at $2.42, down 5.09%, amid broader healthcare-sector weakness; no clear company-specific catalyst surfaced for September 29, 2026. -...
🔴 Neuronetics is trading 5% down today amid U.S. stocks' decline
Neuronetics is trading 5.11% lower at $2.60, with the broader market’s decline offering context for the move. - No clear company-specific announcement or...
🟢 Neuronetics is trading 5.75% up today as broader risk appetite improves
Neuronetics is trading 5.75% up at $2.92 as broader risk appetite improved on September 17, 2026. - Nasdaq Composite rose 1.41% and S&P 500 rose 0.93%,...
🔴 Neuronetics is trading 5% down today after Federal Reserve rate hike pressured growth shares
Neuronetics is trading 5.18% down now at $2.65 after the Federal Reserve raised rates 25 basis points on September 16, 2026. - A hawkish policy outlook, firm...
🔴 Neuronetics is trading 6.37% down today as 10-year Treasury yield reaches 5.02%
Neuronetics is trading 6.37% down at $2.72, mainly amid global risk-off conditions, with the 10-year Treasury yield reaching 5.02%, elevated oil prices, and...
🔴 Neuronetics is trading 7.16% down in pre-market
Neuronetics is trading 7.16% down in pre-market at $2.70, after falling from its September 14 close of $2.90. - Searches found no new earnings release,...
🟢 Neuronetics is trading 5.61% up today after B. Riley initiated Buy coverage
Neuronetics is trading 5.61% up at $3.21 after B. Riley initiated Buy coverage on September 11, 2026, with a $5.00 price target. - The analyst cited...
🟢 Neuronetics is trading 6.60% up in pre-market after B. Riley initiated Buy coverage
Neuronetics is trading 6.60% up at $3.23 after B. Riley initiated Buy coverage with a $5.00 price target on September 11, 2026. - The analyst cited...
Neuronetics Rated Buy at B. Riley, Targeting $5 on Greenbrook Integration
B. Riley initiated coverage on Neuronetics with a Buy rating. The firm set a $5.00 price target. This valuation suggests significant upside from the $3.01...
🟢 Neuronetics is trading 6% up today; catalyst remains unclear
Neuronetics is trading 6% up at $3.10, based on live price context; the catalyst remains unclear. - No September 9, 2026 company-specific announcement,...
🟢 Neuronetics is trading 5.88% up today with no fresh company-specific catalyst identified
Neuronetics is trading 5.88% up now at $2.88, with no fresh company-specific catalyst identified. - No fresh company-specific announcement, earnings release,...
🟢 Neuronetics is trading 7.94% up in pre-market with no fresh company-specific catalyst identified
Neuronetics is trading 7.94% up at $2.99 after no fresh company-specific catalyst was identified for September 3, 2026. - Latest confirmed developments were...
🟢 Neuronetics is trading 5.3% up in pre-market with no confirmed catalyst
Neuronetics is trading 5.28% up at $2.99 in pre-market on September 1, 2026, with no confirmed company-specific catalyst identified. - Recent second-quarter...